《新股表現》時代天使(06699.HK)暗盤高開近91%報330元
根據輝立交易平台顯示,明天掛牌的時代天使科技(06699.HK)暗盤高開近91%報330元,高低見336元/320元,現造332元,較上市價173元,高92%,成交31萬股。
時代天使是內地領先隱形矯治解決方案提供商。是次來港上市合共發售1,682.96萬股,其中10%公開發售獲逾2,078倍超購,已啟動回撥機制佔比增至50%,認購一手中籤率僅1.5%;股份以招股範圍(147-173元)上限定價,料集資淨額約27.22億元,主要用作為創美基地的建設提供資金、提升公司研發能力和為內部與合作研發項目提供資金、開發智能信息技術系統、擴大內部銷售團隊、營銷品牌推廣及培養醫學人才等。上市聯席保薦人分別為高盛及中金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.